In this study, we want to see if a new medicine is safe and works well for adults with multiple myeloma cancer. These adults have already tried at least two other treatments, including specific types of medicines. This study can help us discover a new, safer treatment for this type of cancer.
Thank you for your interest, but this study will start enrolling soon.
North Carolina (Statewide)
Eben Lichtman
LCCC - Clinical Trials
Clinical or Medical
Interventional
Blood Conditions
Cancer (Multiple Myeloma)
24-0396
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
